Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Accumulated Depreciation (2011 - 2022)

Talphera (TLPH) posted Accumulated Depreciation of $11.6 million for Q4 2022, up 0.77% on a QoQ basis from $11.5 million in Q3 2022, and up 7.48% year-over-year from $10.8 million in Q4 2021.

Analysis

Talphera (TLPH) Accumulated Depreciation (2011 - 2022) Analysis & Trends

Talphera has reported Accumulated Depreciation for 12 years, with the latest figure at $11.6 million in Q4 2022.

  • On a quarterly basis, Accumulated Depreciation rose 7.48% year-over-year to $11.6 million in Q4 2022; TTM through Dec 2022 was $11.6 million, a 7.48% increase from a year earlier, with the FY2022 full-year figure at $11.6 million, up 7.48% from the prior year.
  • Accumulated Depreciation was $11.6 million for Q4 2022 at Talphera, up from $11.5 million in the prior quarter.
  • The five-year high for Accumulated Depreciation was $11.6 million in Q4 2022, with the low at $8.9 million in Q4 2018.
  • Average Accumulated Depreciation over 5 years is $10.6 million, with a median of $10.8 million recorded in 2021.
  • The sharpest annual moves came in 2020 and 2021: Accumulated Depreciation gained 10.86% in 2020, then gained 1.86% in 2021.
  • Over 5 years, Accumulated Depreciation stood at $8.9 million in 2018, then increased by 6.8% to $9.6 million in 2019, then increased by 10.86% to $10.6 million in 2020, then rose by 1.86% to $10.8 million in 2021, then advanced by 7.48% to $11.6 million in 2022.
  • The last three Accumulated Depreciation figures came in at $11.6 million (Q4 2022), $11.5 million (Q3 2022), and $11.3 million (Q2 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Talphera 92.90 Mn 92.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 11.59 Mn
Sep 30, 2022 11.50 Mn
Jun 30, 2022 11.29 Mn
Dec 31, 2021 10.79 Mn
Dec 31, 2020 10.59 Mn
Dec 31, 2019 9.55 Mn
Dec 31, 2018 8.94 Mn
Dec 31, 2017 8.44 Mn
Dec 31, 2016 6.74 Mn
Dec 31, 2015 4.85 Mn
Dec 31, 2014 2.96 Mn
Dec 31, 2013 2.10 Mn
Dec 31, 2012 1.51 Mn
Dec 31, 2011 2.05 Mn